Jatropha Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.10 Cr
- Revenue Growth %
- Profit Growth 5.95%
- Ebitda 14.23%
- Net Worth -0.87%
- Total Assets -0.19%
About Jatropha Biotech
Jatropha Biotech Private Limited (JBPL) is a Private Limited Indian Non-Government Company incorporated in India on 22 November 2005 and has a history of 19 years and two months. Its registered office is in Bikaner, Rajasthan, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹3.10 Cr.
Sunil Sardhana and Vijay Gurjar serve as directors at the Company.
Company Details
-
Location
Bikaner, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U01122RJ2005PTC021643
-
Company No.
021643
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
22 Nov 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Jatropha Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sunil Sardhana
|
Director | 28-May-2018 | Current |
|
Vijay Gurjar
|
Director | 01-Jul-2008 | Current |
Financial Performance of Jatropha Biotech.
Jatropha Biotech Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 5.95% increase in profit. The company's net worth dipped by a decrease of 0.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Jatropha Biotech?
In 2020, Jatropha Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Aloe Vera Biotech Private LimitedSunil Sardhana is a mutual person
-
Krishan Gopal Mines Private Limited
Sunil Sardhana and Vijay Gurjar are mutual person
Charges (Loans)
₹31.00 M
₹0
Charges Breakdown by Lending Institutions
- Kotak Mahindra Bank Limited : 3.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Aug 2012 | Kotak Mahindra Bank Limited | ₹6.00 M | Open |
| 14 Feb 2012 | Kotak Mahindra Bank Limited | ₹2.50 Cr | Open |
How Many Employees Work at Jatropha Biotech?
Unlock and access historical data on people associated with Jatropha Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Jatropha Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Jatropha Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
